GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Taiyen Biotech Co Ltd (TPE:1737) » Definitions » Shares Outstanding (EOP)

Taiyen Biotech Co (TPE:1737) Shares Outstanding (EOP) : 200 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Taiyen Biotech Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Taiyen Biotech Co's shares outstanding for the quarter that ended in Sep. 2024 was 200 Mil.

Taiyen Biotech Co's quarterly shares outstanding stayed the same from Jun. 2024 (200 Mil) to Sep. 2024 (200 Mil).

Taiyen Biotech Co's annual shares outstanding stayed the same from Dec. 2022 (200 Mil) to Dec. 2023 (200 Mil).


Taiyen Biotech Co Shares Outstanding (EOP) Historical Data

The historical data trend for Taiyen Biotech Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiyen Biotech Co Shares Outstanding (EOP) Chart

Taiyen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 200.00 200.00 200.00 200.00 200.00

Taiyen Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 200.00 200.00 200.00 200.00 200.00

Competitive Comparison of Taiyen Biotech Co's Shares Outstanding (EOP)

For the Household & Personal Products subindustry, Taiyen Biotech Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co's Shares Outstanding (EOP) Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's Shares Outstanding (EOP) falls into.



Taiyen Biotech Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Taiyen Biotech Co  (TPE:1737) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Taiyen Biotech Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Taiyen Biotech Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiyen Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.

Taiyen Biotech Co Headlines

No Headlines